Sofinnova Investments, Inc.

Q4 2020 13F Holdings Report, Stock Holdings

Signature - Title
Nathalie Auber - Attorney-in-Fact
Location
Menlo Park, CA
Holdings as of
31 Dec 2020
Value $
$1,612,852,000
Num holdings
63
Filing time
16 Feb 2021, 16:04:51 UTC
Form type
13F-HR
Description
All US holdings of this investor are reported in this report. Top holdings included NTRA, KRTX, ASND, YMAB, and UTHR.
Previous filing
Q3 2020 - 13 Nov 2020
Next filing
Q1 2021 - 14 May 2021
SEC
View on sec.gov
Options Holdings
Showing stock holdings, see here for options holdings
Sym Weight Trade Impact Company Class Share Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2020 Q4 compared to 2020 Q3 by default. Changes are calculated vs the previous SEC filing.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Nathalie Auber Attorney-in-Fact Menlo Park, California 16 Feb 2020

Sofinnova Investments, Inc. is filing this Form 13F on behalf of itself and the general partner entities of the investment funds for which it serves as the investment adviser, Sofinnova Management VII, L.L.C., Sofinnova Management VIII, L.L.C., Sofinnova Management IX, L.L.C., Sofinnova Management X, L.L.C., and Sofinnova BioEquities GP LLC.